Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Pfizer Inc. PFE's Covid Vaccine and Pill Provide Unexpected Boost

February 05, 2025
Pfizer Inc. (NYSE:PFE) has received an unexpected boost from its Covid-19 vaccine and recently announced antiviral pill. The company's stock has witnessed a significant increase in value as a result. This news comes amidst concerns over the Kennedy threat to vaccines, which has overshadowed Pfizer's positive developments.

The global demand for Covid-19 vaccines remains high, and Pfizer's vaccine has been one of the most successful options available. The company's vaccine has been authorized for emergency use in numerous countries, helping to combat the ongoing pandemic.

In addition to the vaccine, Pfizer recently announced the successful development of an antiviral pill to treat Covid-19. This pill has shown promising results in clinical trials and could further boost Pfizer's position in the pharmaceutical market.

Despite these positive developments, some investors remain skeptical about Pfizer's stock, considering it to be undervalued. However, financial experts advise against selling Pfizer's stock at its current price as they believe it has the potential for further growth.

Investment advisor, Jim Cramer, shares this sentiment, stating that Pfizer's stock is currently trading too low to sell. He recommends that investors consider buying Pfizer's stock, especially given the long-term potential and low risk associated with the company.

For those interested in investing in Pfizer, seeking the advice of professionals from Stocks Prognosis is recommended. These experts have extensive knowledge of the stock market and can provide valuable insights into the potential movement of Pfizer's stock.

In conclusion, Pfizer Inc. (PFE) has received an unexpected boost from its successful Covid-19 vaccine and the development of an antiviral pill. Despite concerns over the Kennedy threat to vaccines, Pfizer's stock has shown significant potential for growth. Investors are advised to consider buying Pfizer's stock for long-term investment, and seeking guidance from professionals at Stocks Prognosis would be wise.
If you want to leave a comment, then you need Login or Register





Other data for PFE

Related data

PFEAugust 21, 2025PFIZER INC. Stock Hits Price Target Forecast with 6.7% Profit: QuantWave Analysis  ~1 min.

PFIZER INC. (PFE) investors celebrated as the stock reached the price target forecast set by QuantWave on August 21st, 2025, resulting in a 6.7% profit....


PFEAugust 21, 2025PFIZER INC. Hits Price Target Forecast with 7.31% Profit Achieved  ~1 min.

QuantWave, the automated forecasting platform, successfully predicted the price movement of PFIZER INC.'s stock with a 7.31% profit realized....


PFEAugust 21, 2025PFIZER INC. Achieves Forecast Price Target with 9.1% Profit on QuantWave  ~1 min.

Pfizer Inc. stock has successfully reached the forecasted price target on QuantWave's automated forecasting platform, resulting in a profit of 9.1%....


PFEJuly 10, 2025PFIZER INC. Stock Hits Price Target Forecast With 10.06% Profit, Boosting QuantWave's Analytics  ~1 min.

On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. stock when it was trading at $23.03....


PFEJuly 10, 2025PFIZER INC. Hits Price Target Forecast with 8.56% Profit Achieved  ~1 min.

On May 2, 2025, QuantWave issued a price target forecast for PFIZER INC. with a signal to go long at $23.34. The predicted direction was realized on July 10, 2025, when the stock reached $25....


PFEJuly 10, 2025PFIZER INC. Hits Price Target Forecast with 6.57% Profit: A Success Story for QuantWave Analytics  ~2 min.

On June 27, 2025, QuantWave, the automated forecasting platform, released a price target forecast for PFIZER INC., signaling a long position with the stock trading at $23.78....


PFEJuly 10, 2025PFIZER INC. Stock Hits Forecast Price Target with 6.27% Profit: A Success Story for QuantWave  ~2 min.

In a recent market development, PFIZER INC. stock has successfully reached the price target forecasted by QuantWave, resulting in a profit of 6.27%....


PFEJuly 10, 2025PFIZER INC. Hits Price Target with 6.35% Profit: A Success Story for QuantWave Forecasting  ~1 min.

PFIZER INC. has recently hit the price target forecasted by QuantWave, achieving a profit of 6.35% for investors. The forecast signal was generated on June 26, 2025, with a price of 23.83 $....


PFEJuly 10, 2025PFIZER INC. Hits Price Target Forecast with 6.09% Profit: QuantWave Analysis  ~1 min.

On June 10, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. (PFE) when the stock was trading at $23.89. Fast forward to July 10, 2025, and the price target of $25....


PFEJuly 10, 2025PFIZER INC. Stock Hits Price Target Forecast with 6.05% Profit  ~1 min.

On June 24, 2025, QuantWave issued a long signal for PFIZER INC. stock when it was trading at $23.9. Analysts predicted a target price of $25....


ABBVDecember 2, 2024AbbVie Inc. ABBV: A Promising Pharmaceutical Stock with Underrated Potential  ~2 min.

AbbVie Inc. (ABBV), a renowned pharmaceutical company, has been gaining attention as one of the most undervalued pot stocks in the market....


GSKJanuary 25, 2025Is GSK plc GSK an Undervalued Defensive Stock for 2025?  ~2 min.

GSK plc (NYSE: GSK) has been gaining attention as a potential undervalued defensive stock for investors looking towards 2025....


VRTXFebruary 14, 2025Vertex Pharmaceuticals Incorporated Reports Strong Q4 2024 Earnings and FDA Approval for Key Drugs  ~1 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has recently reported its fourth-quarter earnings for 2024, exceeding expectations and driving its stock price higher....


ATODecember 29, 2024Is Atmos Energy Undervalued? Discover the Hidden Potential  ~2 min.

Despite the current market trend, Atmos Energy Corporation has remained under the radar of many investors....


AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....